Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema

Macular Diseases

Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedema

Br J Ophthalmol

Chalkiadaki E, Sim YS, Williams O, Elder L, Addison PK, Hamilton RD, Nicholson L, Sivaprasad S, Heng LZ

doi: 10.1136/bjo-2025-328893

Macular DiseasesRetinal Diseases

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Sci Rep

Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y, J-CREST

doi: 10.1038/s41598-025-20300-6

Macular DiseasesRetinal Diseases

Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review

Surv Ophthalmol

Nanji K, Hatamnejad A, Grad J, El-Sayes A, Mihalache A, Gemae M, Huang R, Phillips M, Zeraatkar D, Singh R, Munk MR, Sadda SR, Sarraf D, Kaiser P, Guymer R, Sivaprasad S, Fraser-Bell S, Tham YC, Garg SJ, Wong TY, Wykoff CC, Chaudhary V

doi: 10.1016/j.survophthal.2025.09.009

Macular DiseasesRetinal Diseases

Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World Setting

Ophthalmol Ther

Borselli M, Elfalah M, Trunfio TA, Scala A, Chisari D, Mancini A, Lucisano A, Carnovale-Scalzo G, Mollace V, Improta G, Zweifel S, Scorcia V, Toro MD, Carnevali A

doi: 10.1007/s40123-025-01232-w

Macular DiseasesRetinal Diseases

Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report

Ophthalmol Ther

Heck K, Hatz K, Cattaneo M, Pfister I, Magnin S, Ruscitti L, Stasik I, Tillmann A, Shamshiev M, Fang J, Weinberger A, Zweifel SA, Garweg JG, Eandi CM, Grimaldi G, Munk MR, Somfai GM, Ambresin A, Feltgen N

doi: 10.1007/s40123-026-01442-w

Macular Diseases

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

BMJ Open Ophthalmol

Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K

doi: 10.1136/bmjophth-2025-002467

Macular Diseases

Dynamics of Hyper-Reflective Foci and Hard Exudates in Diabetic Macular Edema Treated with Faricimab

J Clin Med

Widmann-Sedlnitzky P, Huber KL, Steiner I, Gumpinger M, Stino H, Schmoll T, Schmidt-Erfurth U, Sacu S, Pollreisz A

doi: 10.3390/jcm15166319

Macular Diseases

Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema

Am J Ophthalmol

Kundu R, Goturi N, Green M, Poulaki V, Siegel NH, Subramanian ML, Ness S

doi: 10.1016/j.ajo.2026.09.002

Glaucoma and Ocular PressureUveitis

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis

Retina

Hamdan SA, Zafar S, Nassur JA, Yonekawa Y, Kuriyan AE, Dunn JP, Cohen MN, Hsu J, Regillo CD, Garg SJ, Xu D, Klufas M, Deaner JD

doi: 10.1097/IAE.0000000000004677

Related content

Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedema

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review

Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World Setting

Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

Dynamics of Hyper-Reflective Foci and Hard Exudates in Diabetic Macular Edema Treated with Faricimab

Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis